Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
- DOI
- 10.1007/s00277-010-0997-y
- Published
- 2010 Nov
- Container
- Annals of hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-010-0997-y,
title = {Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.},
author = {Peñalver FJ and Alvarez-Larrán A and Díez-Martin JL and Gallur L and Jarque I and Caballero D and Díaz-Mediavilla J and Bustelos R and Fernández-Aceñero MJ and Cabrera JR and Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA},
year = {2010},
journal = {Annals of hematology},
doi = {10.1007/s00277-010-0997-y},
url = {https://doi.org/10.1007/s00277-010-0997-y}
}RIS
TY - JOUR TI - Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. AU - Peñalver FJ AU - Alvarez-Larrán A AU - Díez-Martin JL AU - Gallur L AU - Jarque I AU - Caballero D AU - Díaz-Mediavilla J AU - Bustelos R AU - Fernández-Aceñero MJ AU - Cabrera JR AU - Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA PY - 2010 JO - Annals of hematology DO - 10.1007/s00277-010-0997-y UR - https://doi.org/10.1007/s00277-010-0997-y ER -
APA
FJ, P., A, A., JL, D., L, G., I, J., D, C., J, D., R, B., MJ, F., JR, C., & AIHA, M. R. S. O. T. U. O. R. I. R. (2010). Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.. Annals of hematology. https://doi.org/10.1007/s00277-010-0997-y
Source records
- pubmed · retrieved 2026-09-26T23:33:21.669Z